EVOGEN, INC.

Lenexa, KS · CIK 0001170875 · Medtech · Private

Blood test that differentiates psychogenic non-epileptic seizures (PNES) from epilepsy

evogen.com →
Grants
$842K
3 awards
Sector median: 1
Raised
$1.9M
2 Form D · Feb 2014
152 months since last filing
Contracts
$841K
4 awards · the Interior, Defense
#340 of 4531 in medtech
Patents
8
3 granted · 5 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of the Interior · Air Sampler$11,379
Federal contractDepartment of Defense · Evaluation Of Units$3,400
Private capital raisedForm D · SEC$1,041,322
Federal contractDepartment of Defense · SBIR Phase I (A103-154-0413)$789,500
Federal contractDepartment of Defense · Ram 31 High Production Dry Stripping Cab$36,406
Private capital raisedForm D · SEC$852,420
Federal grantDepartment of Health and Human Services · Phase I · Diagnostic Test for Detecting Recent Seizures in Epilepsy Patients$224,515
Federal grantDepartment of Health and Human Services · Phase I · Assessment of Peripherally Circulating Plasma Proteins and Clinical Risks to Differentiate Epileptic Seizure from Psychogenic Nonepileptic Seizure$562,119
Federal grantDepartment of Health and Human Services · Phase I · Assessment of Peripherally Circulating Plasma Proteins and Clinical Risks toDifferentiate Epileptic Seizure from Psychogenic Nonepileptic Seizure$55,000
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
337MICHIGAN CRITICAL CARE CONSULTANTS, INC.$849K$34M
338MEMSEL INC.$844K—
339EASEALERT LLC$842K$200K
340EVOGEN, INC.$841K$1.9M
341BOOST TREADMILLS LLC$807K—
342Ninepoint Medical, Inc.$783K$70M
343GRADIENT HEALTH, INC.$766K$7.9M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 9 related persons
  • Robert DondesExecutive Officer
  • Thomas JantschDirector · Executive Officer
  • Hans KastensmithDirector · Executive Officer · Promoter
  • Nathan LedeboerDirector
  • Jonathan LeitersdorfDirector
  • John LevyDirector
  • Sean ReinekeDirector
  • James SpigarelliDirector
  • Richard St. ClairExecutive Officer

Patents

USPTO · 3 granted of 8

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.